Fig. S1. Expression levels of miR-122 in normal colon mucosae, primary colorectal cancers, and colorectal liver metastases of the same six patients by quantitative RT-PCR.

Fig. S2. Correlation between the expression levels of miR-122 and cationic amino acid transporter 1 (CAT1) protein in six colorectal liver metastases.

Fig. S3. Expression levels of cationic amino acid transporter 1 (CAT1) and miR-122 by quantitative RT-PCR in colorectal adenocarcinoma cell lines DLD-1, SW480, and HCT116.

Fig. S4. Liver metastasis-free survival by cationic amino acid transporter 1 (CAT1) positivity in 46 primary colorectal cancers of patients who received adjuvant chemotherapy after surgery for stage II or III colorectal cancer.

cas12122-sup-0002-DataS1.pdfapplication/PDF103KDoc. S1. Materials and methods.
cas12122-sup-0003-TableS1.xlsxapplication/msexcel12KTable S1. Top 20 miRNAs up- and downregulated in metachronous liver metastasis compared with primary tumors as assessed by microRNA arrays.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.